Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
- Resource Type
- Review Article
- Source
- In
Biomedicine & Pharmacotherapy February 2024 171 - Subject
- Language
- ISSN
- 0753-3322